ACTOnco®+ Provides Comprehensive Options For Your Strategy
In the medical journey of cancer treatment, precision medicine is recognized as a modern and favored way for healthcare system to take care of cancer patients more easily. Challenges of identifying the right drug to every cancer patient while new drugs are emerging for specific genomic mutations can be tackled strategically by having cancer patients’ unique cancer genomic profiles. The acceleration of oncology drug approvals and the modernization of clinical trials with biomarker-based patients have progressed well as USFDA committed from 2018. The wave of precision medicine also increases approvals of companion diagnostics, bringing ACT Genomics’ genomic profiling service on the waiting list of USFDA approval.
Why You Need To Know About Precision Medicine
Top global pharma companies fasten the pace to conduct clinical trials of precision medicine, which requires cancer patients’ genomic information via genomic profiling. This evolution affects most hospitals, so you need to get prepared for the genomic profiling if you are always looking for a new treatment.
You may feel pity for some road not taken in your life, but in cancer treatment, we must all take the right path without any regret! A generic treatment guidance can help, but not always. A personalized approach, precision medicine, is still better to assist physicians and patients to confidently walk through the dynamic maze directed by genomic mutations, and a study has shown that precision medicine doubles the percentage of cancer patients who achieved tumor shrinkage. The power of genomics should never be underestimated, even 440 genes may change cancer patients’ life dramatically, by matching the right immunotherapy, targeted therapy, chemotherapy, and hormonal therapy in time.
? Chemotherapy and surgery are the only options according to NCCN guideline or single gene test result
? Complicated and metastases, hard to know the appropriate drugs
? Ineffective treatment, and cancer relapse after targeted therapy
? Pursue for immunotherapy, targeted therapy and wondering the effect
Diagnostic Solutions For All Cancers
Through Next Generation Sequencing (NGS), ACTOnco®+ comprehensive genomic profiling decodes >400 cancer genes to map drug options via many clinical researches, not limit to single clinical treatment guideline. ACTOnco®+ controls the growth mechanism from genomic level and enables more treatment strategy with higher success rate. Suitable for ovarian and breast cancer. If single gene test does not bring satisfying result, NGS genomic profiling can detect special genomic mutations for better treatment.
Comprehensive Genomic Profiling Can Bring Treatment Advantages As Follows:
? More humanized process : Avoid multiple biopsies and time cost of single gene test, only few specimen required for >400 genes detection at once.
? More ideal treatment : Find proper targeted options, immunotherapy, chemotherapy or hormonal therapy
? Plan medical budget more intelligently : Evaluate options before treatment according to genomic information, to ensure success rate and avoid waste of medical budget.
Listen To The Successful Fighters' StoriesMany cancer patients are diagnosed late stage, and some patients will know precision medicine is because they have medical background or being recommended by physicians. Listen to their stories and help them bring hope to more people.
Cancer Patient Stories :
? Who Can Use : Patients with solid tumors
? Specimen Type : Tumor sample
? Turnaround Time : 10 working days after qualified specimen is received